We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-3.67%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$40.3B
AUM Growth
-$1.82B
(-4.3%)
Cap. Flow
+$332M
Cap. Flow
% of AUM
0.83%
Top 10 Holdings %
Top 10 Hldgs %
25.24%
Holding
2,393
New
237
Increased
785
Reduced
642
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$231M |
| 2 |
Gilead Sciences
GILD
|
+$113M |
| 3 |
PG&E
PCG
|
+$102M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$80.2M |
| 5 |
Allstate
ALL
|
+$64.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$472M |
| 2 |
AbbVie
ABBV
|
+$121M |
| 3 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$69.5M |
| 4 |
Salesforce
CRM
|
+$64.3M |
| 5 |
Home Depot
HD
|
+$62.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.24% |
| 2 | Healthcare | 19.03% |
| 3 | Financials | 13.02% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Industrials | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Ligand Pharmaceuticals
LGND
$5.85B
| $581K | ﹤0.01% |
10,811
| – | – |
|
|
RWT
1377
Redwood Trust
RWT
$582M
| $581K | ﹤0.01% |
101,300
| – | – |
|
|
PINC
1378
DELISTED
Premier
PINC
| $580K | ﹤0.01% |
17,090
+15,010
| +722% | +$547K |
|
1379
Novanta
NOVT
$4.88B
| $577K | ﹤0.01% |
4,990
+3,020
| +153% | +$411K |
|
1380
Tanger
SKT
$4.82B
| $576K | ﹤0.01% |
42,090
| – | – |
|
|
JWN
1381
DELISTED
Nordstrom
JWN
| $575K | ﹤0.01% |
34,350
-4,000
| -10% | -$83.5K |
|
1382
Kirby Corp
KEX
$7.17B
| $573K | ﹤0.01% |
9,437
-960
| -9% | -$61.5K |
|
1383
Super Micro Computer
SMCI
$17.3B
| $572K | ﹤0.01% |
+103,800
| New | +$591K |
|
|
AQUA
1384
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $570K | ﹤0.01% |
17,230
+12,250
| +246% | +$445K |
|
|
ODP
1385
DELISTED
ODP
ODP
| $568K | ﹤0.01% |
16,160
| – | – |
|
|
TWO
1386
Two Harbors Investment
TWO
$1.27B
| $568K | ﹤0.01% |
42,775
| – | – |
|
1387
InterDigital
IDCC
$6.81B
| $567K | ﹤0.01% |
14,018
| – | – |
|
1388
BWX Technologies
BWXT
$14.8B
| $566K | ﹤0.01% |
+11,230
| New | +$606K |
|
1389
Interparfums
IPAR
$4.04B
| $564K | ﹤0.01% |
7,475
-320
| -4% | -$25.4K |
|
1390
Dyne Therapeutics
DYN
$4.19B
| $562K | ﹤0.01% |
44,270
+4,270
| +11% | +$49K |
|
1391
Macerich
MAC
$7.47B
| $561K | ﹤0.01% |
70,594
| – | – |
|
1392
Addus HomeCare
ADUS
$2.23B
| $560K | ﹤0.01% |
5,880
| – | – |
|
|
SPWR
1393
DELISTED
SunPower Corporation Common Stock
SPWR
| $560K | ﹤0.01% |
24,310
+7,650
| +46% | +$172K |
|
|
BCYC
1394
Bicycle Therapeutics
BCYC
$272M
| $559K | ﹤0.01% |
24,033
+5,773
| +32% | +$137K |
|
|
HBI
1395
DELISTED
Hanesbrands
HBI
| $558K | ﹤0.01% |
80,202
-1,084
| -1% | -$10.6K |
|
1396
ScottsMiracle-Gro
SMG
$4.03B
| $558K | ﹤0.01% |
13,057
| – | – |
|
|
NBIS
1397
Nebius Group N.V.
NBIS
$38.5B
| $558K | ﹤0.01% |
22,300
| – | – |
|
1398
Nu Skin
NUS
$253M
| $556K | ﹤0.01% |
16,650
-3,370
| -17% | -$140K |
|
1399
Renasant Corp
RNST
$4.02B
| $555K | ﹤0.01% |
17,750
| – | – |
|
1400
Telephone and Data Systems
TDS
$3.83B
| $555K | ﹤0.01% |
39,914
| – | – |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Ensign Peak Advisors held 2,393 positions worth $40.3B, down 4.3% from $42.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ensign Peak Advisors's Q3 2022 filing shows 237 new, 785 increased, 642 reduced and 83 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M. The largest sale was Visa, an estimated $472M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q3 2022 buy was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M.
- Ensign Peak Advisors added most to Mastercard in Q3 2022, an estimated $231M increase.
- Ensign Peak Advisors's biggest Q3 2022 reduction was AbbVie, cutting an estimated $121M.
- Ensign Peak Advisors fully exited Visa in Q3 2022, selling an estimated $472M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $40.3B portfolio in Q3 2022.
- Ensign Peak Advisors opened 237 new positions and closed 83 in Q3 2022.
- Ensign Peak Advisors's portfolio value fell 4.3% quarter-over-quarter to $40.3B.
Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.